| Dr Richard Hayden Jones, MD | |
|
171 Ashley Ave, Charleston, SC 29425-8908 | |
| (843) 792-1414 | |
| Not Available |
| Full Name | Dr Richard Hayden Jones |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 12 Years |
| Location | 171 Ashley Ave, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003172891 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Musc Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Associates Of The Medical University Of South Carol | 6305758574 | 1297 |
News Archive
The National Cancer Institute (NCI) has awarded Beth Israel Deaconess Medical Center (BIDMC) an $11.5 million, five-year SPORE grant to focus on cancers of the kidney. Michael Atkins, MD, Deputy Director of BIDMC's Division of Hematology/Oncology, will oversee the grant, which involves collaborations with Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital via the Dana-Farber/Harvard Cancer Center.
A recent study evaluating the use of force by police against children found that Black and Hispanic adolescents are significantly more likely to die from shootings related to police intervention compared to non-Hispanic white adolescents.
Fight for Sight is encouraging applicants to apply for the Project Grants Awards. The call for the £250k award to undertake a three year project, is now open.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter ended March 31, 2010, and company highlights.
› Verified 6 days ago
| Entity Name | University Medical Associates Of The Medical University Of South Carol |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043241110 PECOS PAC ID: 6305758574 Enrollment ID: O20031105000291 |
News Archive
The National Cancer Institute (NCI) has awarded Beth Israel Deaconess Medical Center (BIDMC) an $11.5 million, five-year SPORE grant to focus on cancers of the kidney. Michael Atkins, MD, Deputy Director of BIDMC's Division of Hematology/Oncology, will oversee the grant, which involves collaborations with Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital via the Dana-Farber/Harvard Cancer Center.
A recent study evaluating the use of force by police against children found that Black and Hispanic adolescents are significantly more likely to die from shootings related to police intervention compared to non-Hispanic white adolescents.
Fight for Sight is encouraging applicants to apply for the Project Grants Awards. The call for the £250k award to undertake a three year project, is now open.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter ended March 31, 2010, and company highlights.
› Verified 6 days ago
| Entity Name | Carolina Family Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184655722 PECOS PAC ID: 4587557731 Enrollment ID: O20040203000627 |
News Archive
The National Cancer Institute (NCI) has awarded Beth Israel Deaconess Medical Center (BIDMC) an $11.5 million, five-year SPORE grant to focus on cancers of the kidney. Michael Atkins, MD, Deputy Director of BIDMC's Division of Hematology/Oncology, will oversee the grant, which involves collaborations with Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital via the Dana-Farber/Harvard Cancer Center.
A recent study evaluating the use of force by police against children found that Black and Hispanic adolescents are significantly more likely to die from shootings related to police intervention compared to non-Hispanic white adolescents.
Fight for Sight is encouraging applicants to apply for the Project Grants Awards. The call for the £250k award to undertake a three year project, is now open.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter ended March 31, 2010, and company highlights.
› Verified 6 days ago
| Entity Name | Musc Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841878006 PECOS PAC ID: 6507260668 Enrollment ID: O20210811002388 |
News Archive
The National Cancer Institute (NCI) has awarded Beth Israel Deaconess Medical Center (BIDMC) an $11.5 million, five-year SPORE grant to focus on cancers of the kidney. Michael Atkins, MD, Deputy Director of BIDMC's Division of Hematology/Oncology, will oversee the grant, which involves collaborations with Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital via the Dana-Farber/Harvard Cancer Center.
A recent study evaluating the use of force by police against children found that Black and Hispanic adolescents are significantly more likely to die from shootings related to police intervention compared to non-Hispanic white adolescents.
Fight for Sight is encouraging applicants to apply for the Project Grants Awards. The call for the £250k award to undertake a three year project, is now open.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter ended March 31, 2010, and company highlights.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Hayden Jones, MD Po Box 751461, Charlotte, NC 28275-1461 Ph: (843) 792-6200 | Dr Richard Hayden Jones, MD 171 Ashley Ave, Charleston, SC 29425-8908 Ph: (843) 792-1414 |
News Archive
The National Cancer Institute (NCI) has awarded Beth Israel Deaconess Medical Center (BIDMC) an $11.5 million, five-year SPORE grant to focus on cancers of the kidney. Michael Atkins, MD, Deputy Director of BIDMC's Division of Hematology/Oncology, will oversee the grant, which involves collaborations with Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital via the Dana-Farber/Harvard Cancer Center.
A recent study evaluating the use of force by police against children found that Black and Hispanic adolescents are significantly more likely to die from shootings related to police intervention compared to non-Hispanic white adolescents.
Fight for Sight is encouraging applicants to apply for the Project Grants Awards. The call for the £250k award to undertake a three year project, is now open.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter ended March 31, 2010, and company highlights.
› Verified 6 days ago
Sai Kiran Gudla, Radiology Medicare: Not Enrolled in Medicare Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2575 | |
Karen L Spodarek, D.O. Radiology Medicare: Medicare Enrolled Practice Location: 316 Calhoun St, Charleston, SC 29401 Phone: 843-724-2154 Fax: 843-805-6277 | |
Johnny Phillips Campbell, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 316 Calhoun St, Charleston, SC 29401 Phone: 843-724-2988 | |
Nancy Curry, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Donna Rae Roberts, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Cody R. Quirk, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |